Literature DB >> 35182223

Metal oxide nanocage as drug delivery systems for Favipiravir, as an effective drug for the treatment of COVID-19: a computational study.

Chunchun Yao1, Feng Xiang1, Zhangyi Xu2.   

Abstract

This paper is a summary of research that looks at the potential of fullerene-like (MO)12 nanoclusters (NCs) in drug-carrying systems using density functional theory. Favipiravir/Zn12O12 (- 34.80 kcal/mol), Favipiravir/Mg12O12 (- 34.98 kcal/mol), and Favipiravir/Be12O12 (- 30.22 kcal/mol) were rated in order of drug adsorption degrees. As a result, Favipiravir attachment to (MgO)12 and (ZnO)12 might be simple, increasing Favipiravir loading efficiency. In addition, the quantum theory of atoms in molecules (QTAIM) assessment was utilized to look at the interactions between molecules. The FMO, ESP, NBO, and Eads reactivity patterns were shown to be in excellent agreement with the QTAIM data. The electrostatic properties of the system with the biggest positive charge on the M atom and the largest Eads were shown to be the best. This system was shown to be the best attraction site for nucleophilic agents. The findings show that (MgO)12 and (ZnO)12 have great carrier potential and may be used in medication delivery.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Density functional theory; Drug delivery; Fullerene; Nucleophilic

Mesh:

Substances:

Year:  2022        PMID: 35182223      PMCID: PMC8857396          DOI: 10.1007/s00894-022-05054-6

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   2.172


Introduction

COVID-19, a new coronavirus, has spread practically everywhere on the globe since late 2019, generating a plethora of serious public health problems [1]. Due to the lack of an antiviral medication that has been authorized, many efforts have been undertaken to investigate pharmaceutical substances for the supportive therapy of the illness [2]. It is critical to look at current drugs as well as novel compounds to determine whether there’s a method to treat COVID-19 swiftly. The structure of COVID-19’s protease was first discovered in early 2020 [3], spurring a substantial investigation into the efficacy of current, comparable medications on enzymatic activity [4]. In addition, identifying the mechanism of action of the ligand-target complex is crucial for moving further in the phases of drug development and design [5-8]. Favipiravir has recently been investigated as a potential COVID-19 therapy, and it has been indicated as a viable option. The development of efficient medicine delivery systems has received a lot of attention recently. As a consequence, nanomaterials are now often utilized to characterize novel drug delivery (DD) methods [5-9]. DD materials include zero-dimensional nanoclusters (NCs), one-dimensional nanotubes, and two-dimensional nanosheets [10-20]. Theoretical investigations have been undertaken on fullerene-like (AB)12 (A = Mg, Al, B… and B = N, P, O…) NCs as more stable cages than other types of (AB)x structures such as nanosheets and nanotubes [21-40]. Th-symmetrical metal oxide NCs, such as (MgO)12, (BeO)12, and (ZnO)12, have also gotten a lot of interest because of their unique features. Previous studies have demonstrated that (BeO)12 is thermally stable, suggesting that it might be synthesized in this manner [41]. Haertelt and coworkers [42] used density functional theory (DFT) and IR spectroscopy to demonstrate the (MgO)12 NCs’ stability. In contrast to (BeO)12 and (MgO)12 NCs, (ZnO)12 NCs have been extensively investigated for their prominent roles in biomedical, gas detector, optoelectronics applications, and as a catalyst [43-54]. Furthermore, (ZnO)x nanocages have proven outstanding efficacy in DD applications due to their improved biocompatibility and reduced cost. The Zn12O12 NC was successfully synthesized [55], and its many uses were investigated [56, 57]. Regardless, few research assessing the efficacy of such NCs in DD systems have been conducted. As a consequence, the present study focuses on adsorbing pharmaceuticals on Zn12O12, Mg12O12, and Be12O12NCs, which have been identified as the optimal clusters for DD systems. The interactions of (MO)12 NCs and Favipiravir were investigated using DFT. The primary goal of this research is to conduct a theoretical investigation of (MO)12/Favipiravir systems to determine if Favipiravir-controlled administration is feasible. The density of state (DOS), adsorption energy, molecule electrostatic potential, UV–vis spectrum, and electronic characteristics were all found as a result of this research. The atoms’ quantum theory of molecules (QTAIM) findings was also used to identify the interactions in terms of nature.

Computational methods

The current study used DFT calculations to better achieve Favipiravir energetic assessments and geometrical relaxation on (MO)12 complexes. This work used the generalized gradient approximation, Perdew-Burke-Ernzerhof (PBE) one, for exchange–correlation energy functional and Grimme dispersion corrected PBE using Gaussian 09 to optimize the geometry and determine the electrical characteristics. Double numerical basis sets, such as polarization functions, have been used to illustrate atomic valent orbitals [58-61]. To get Favipiravir adsorption energy, the energy difference between the solitary NC-Favipiravir assembly and Favipiravir/NC complexes was discovered. In order to determine if the expected (MO)12 NCs could be experimentally manufactured, the cohesive energy Ecoh was computed as follows: where Etot denotes the overall energy of the NCs is, Ei represents the atomic energy, ni is the number of type-i atoms (i = Zn, O, Be, and Mg) and j is the number of the total atoms of (MO)12. It was necessary to quantify the energy gap (Eg) of the lowest and highest occupied molecular orbitals in order to assess Favipiravir adsorption contributions to NC electrical characteristics (LUMO and HOMO). Natural bond orbital (NBO) analysis of charge was used to assess charge transfer between drug molecules and NCs [62]. AIMALL was also used to create QTAIM and better understand the complexes’ interactions [63].

Results and discussion

Structural and electronic characteristics of intact (MO) NCs

The intact (MO)12 and optimized Favipiravir structures are shown in Fig. 1. As can be observed, the intact NCs have six tetragons and eight hexagons with symmetry of Th. (MgO)12, (BeO)12, and (ZnO)12 have the angles of a hexagon (tetragon) of 114.2 (86.6), 111.8 (80.8), and 108.6 (86.9) degrees, respectively. Two forms of M–O bonds exist in the NCs: a hexagonal double bond (d1) as well as bonds shared by a hexagon and a tetragon (d2). The bond sizes of d1 (d2) of (BeO)12, (MgO)12, and (ZnO)12, respectively, are 1.54(1.60), 1.88(1.95), and 1.89(1.99) Å. The current study used the calculations of harmonic vibrational frequency at the level of the theory of PBE/6–31 + g(d) to guarantee that the structures corresponded to energy minima. On the surface of potential energy, the structures were discovered to be real stationary points. (BeO)12, (MgO)12, and (ZnO)12 have harmonic frequencies of 200.6–1194.1 cm−1, 100.6–764.2 cm−1, and 74.8–650.2 cm−1, respectively. The results are consistent with those of Li and coworkers [64], who investigated NC acetone sensitivity. The NC electrostatic potential (ESP) graphs are shown in Fig. 2, with the red negative regions representing relative charge buildup and the blue positive regions representing charge depletion.
Fig. 1

The optimized structures of Favipiravir drug and intact (MO)12 NCs

Fig. 2

The analysis of ESP and the LUMO and HOMO of the intact (MO)12 NCs

The optimized structures of Favipiravir drug and intact (MO)12 NCs The analysis of ESP and the LUMO and HOMO of the intact (MO)12 NCs Based on Fig. 2, the best attraction locations for nucleophilic agents are Be, Mg, and Zn atoms. The top perspective for intact NCs’ frontier molecular orbital (FMO) is also shown in Fig. 2. As can be observed, the NC HOMOs were discovered to have a preferential distribution on O atoms. As a consequence of the FMO findings, the optimum nucleophilic agent attraction regions of the Be, Mg, and Zn atoms were discovered. The NCs were evaluated using the NBO method. The atomic charges of NBO on the Be, Mg, and Zn atoms were shown to be + 1.16, + 1.16, and + 1.32 e, respectively, indicating a considerable charge transfer from the mentioned atoms to the O atom. Ecoh was also computed using Eq. (1), proving that the expected nanoclusters could be manufactured experimentally. For Be12O12, Zn12O12, and Mg12O12, Ecoh was determined to be − 7.25, − 5.55, and − 5.76 eV, respectively. According to the findings, (BeO)12 has a lower Ecoh than (MgO)12 and (ZnO)12, implying that (BeO)12 might be simpler to produce than (MgO)12 and (ZnO)12. For (BeO)12, (MgO)12, and (ZnO)12, Eg was shown to be 7.23, 3.85, and 2.13 eV, respectively. The Eg findings were inconsistent with previous research [64]. The DOS findings are shown in Fig. 3 so that the influence of the M atom on the NC electronic characteristics can be checked. Large differences emerged towards the Fermi level, as can be shown, due to significant interactions of M–O on both sides. In addition, the valence level for (ZnO)12 increases in energy as the conduction level decreases. Eg is significantly reduced as a result of this. As a result, (ZnO)12 (Eg = 2.13 eV) may be classified as a semiconductor nanoparticle, while (BeO)12 (Eg = 7.23 eV) and (MgO)12 (Eg = 3.85 eV) are often metal oxides that have been insulated.
Fig. 3

DOS diagrams for the intact (MO)12 NCs

DOS diagrams for the intact (MO)12 NCs

Favipiravir adsorption on the (MO)12 NCs

Energetic evaluation

The current study looked at a range of configurations to find the most stable adsorption on the NC surface, such as placing Favipiravir oxygen, nitrogen, and fluorine atoms at various positions, such as the tops of Mg, Zn, O, and Be atoms, as well as the tetragonal and hexagonal ring centers. Eads, the shortest NC-drug distance, and the most stable electronic configurations are shown in Fig. 4. Based on Fig. 4, the optimized-geometry Favipiravir has the maximum propensity for O and M atom interaction. This is in line with the ESP and FMO findings. The interaction distances of the Favipiravir/Be12O12, Favipiravir/Zn12O12, and Favipiravir/Mg12O12 complexes are also shown in Fig. 4. As can be observed, the interaction distances between Favipiravir/Zn12O12 and Favipiravir/Mg12O12 are quite short. As a consequence, it is safe to assume that chemisorption will take place.
Fig. 4

The most stable electronic configurations of the adsorbed Favipiravir on (MO)12 NCs’ surface

The most stable electronic configurations of the adsorbed Favipiravir on (MO)12 NCs’ surface The adsorption energies of (BeO)12, (ZnO)12, and (MgO)12 were shown to interact with Favipiravir at − 30.22, − 34.80, and − 34.98 kcal/mol, respectively. Since Favipiravir adsorptions onto (ZnO)12 and (MgO)12 have great adsorption energy levels, the Favipiravir molecule is chemisorbed onto the nanocluster. The lower interaction lengths between the drug O and H atoms and the nanocluster O and M atoms explain this. As a consequence, it can be stated that (MgO)12 and (ZnO)12 are more suitable for Favipiravir adsorption. These results are in good agreement with the ESP, NBO, and FMO reactivity patterns. The largest positive charge on the M atom as the best attraction site of the nucleophilic agent is represented by the Eads maximum level of Favipiravir/(MO)12. The current study looked at the influence of a solvent on Favipiravir adsorption onto NCs in aqueous conditions. The polarizable continuum model was used to quantify the influence of water as the solvent (ε = 78.4). According to the results of Eads, the complexes were compared in aqueous and gaseous phases (Table 1). As can be observed, the energy levels in both phases are fully negative, indicating that the complexes are stable. The greater the possible solubility of the NC to affect the Favipiravir-NC interaction, the larger the absolute amount of negative adsorption energy in the aqueous phase. The DOS data are shown in Fig. 5 to validate the impacts of Favipiravir on NC electronic characteristics. As shown in Fig. 6, (MgO)12 and (ZnO)12 displayed minor post-Favipiravir adsorption modifications in LUMO and HOMO. As a result, Eg stayed almost unaltered. The valence (conduction) level of Favipiravir/(BeO)12, on the other hand, rose (reduced). As a consequence, the Eg of (BeO)12 was smaller than that of its immaculate equivalent.
Table 1

Comparison of the values of Eads (kcal/mol) obtained in the solution and gas phase for the complexes of Favipiravir/(MO)12

MoleculeGas phaseSolution
Favipiravir/Be12O12 − 30.22 − 41.11
Favipiravir/Mg12O12 − 34.98 − 46.65
Favipiravir/Zn12O12 − 34.80 − 47.75
Fig. 5

DOS diagrams for Favipiravir/(MO)12 compounds

Fig. 6

Molecular diagram of Favipiravir/(MO)12 compounds. Bond pathways are shown by the lines

Comparison of the values of Eads (kcal/mol) obtained in the solution and gas phase for the complexes of Favipiravir/(MO)12 DOS diagrams for Favipiravir/(MO)12 compounds Molecular diagram of Favipiravir/(MO)12 compounds. Bond pathways are shown by the lines

UV–Vis spectra

At the level of the theory of PBE/6–31 + g(d), the UV–Vis spectrum of both pure NCs and Favipiravir-nanocluster complexes were measured. Table 2 lists the important transitions (i.e., the greatest oscillator strengths (f)). Based on Table 2, the greatest adsorption wavelengths of the intact (BeO)12, (ZnO)12, and (MgO)12 were determined to be 294.72, 372.36, and 411.45 nm, respectively. The greatest oscillator strengths were 0.1241, 0.0032, and 0.0035, respectively. The majority of adsorption wavelength peaks are explained by HOMO → LUMO transitions. The intact NC adsorption bands dropped to higher wavelengths when Favipiravir was adsorbed onto them. Thus, it is possible to deduce that the electronic spectrum of the complexes experiences a redshift to higher wavelengths. The most significant redshift was seen in Favipiravir/(BeO)12 (126 nm).
Table 2

The estimated maximum value of absorption wavelength (λ), the transition of dominant contribution for the intact (MO)12 and Favipiravir/(MO)12 and complexes, and oscillator strengths (f)

complexesλ (nm)f0Major contribution
Be12O12168.210.0024HOMO → LUMO (71%)
Favipiravir/Be12O12294.720.1241HOMO → LUMO (74%)
Mg12O12300.310.0049HOMO → LUMO (71%)
Favipiravir/Mg12O12411.450.0035HOMO → LUMO (76%)
Zn12O12348.980.0093HOMO → LUMO (70%)
Favipiravir/Zn12O12372.360.0032HOMO → LUMO (75%)
The estimated maximum value of absorption wavelength (λ), the transition of dominant contribution for the intact (MO)12 and Favipiravir/(MO)12 and complexes, and oscillator strengths (f)

AIM analysis

AIM is a capable tool for determining the interactions between molecules. AIM can identify the bond critical points (BCPs) between interactive systems using topological variables. The improved Favipiravir/NC complexes are shown as molecular graphs in Fig. 6. Based on Table 2, at BCPs, the computed values of ρc for the complexes range from 0.0341 to 0.0762 a.u. The ∇2ρc values also range from 0.0542 to 0.145 a.u. The ρc values are raised when Mg and Zn atoms replace the NC’s M atom (Table 3).
Table 3

The Laplacian of electron density (∇2ρ), electron density (ρ), total electron energy density (H) in a.u., potential energy density (V), kinetic energy density (K), and at BCPs in the Favipiravir-adsorbed compounds by AIM analysis

ComplexesBCP∇2ρρK(r)V(r)H(r)K(r)/׀V(r)׀
Favipiravir/Be12O12Be18-O350.4310.0601 − 0.0067 − 0.0944 − 0.00670.0709
O2-H370.1090.03410.0010 − 0.029 − 0.00100.0344
Favipiravir/Mg12O12

Mg6-O35

O14-H36

0.269

0.154

0.0360

0.0522

 − 0.0110

0.0032

 − 0.0452

 − 0.0451

 − 0.0110

 − 0.0032

0.2433

0.0709

Favipiravir/Zn12O12

Zn17-O35

O8-H37

0.319

0.145

0.0762

0.0470

0.0251

0.0025

 − 0.1303

 − 0.0413

 − 0.0251

 − 0.0025

0.1926

0.0605

The Laplacian of electron density (∇2ρ), electron density (ρ), total electron energy density (H) in a.u., potential energy density (V), kinetic energy density (K), and at BCPs in the Favipiravir-adsorbed compounds by AIM analysis Mg6-O35 O14-H36 0.269 0.154 0.0360 0.0522 − 0.0110 0.0032 − 0.0452 − 0.0451 − 0.0110 − 0.0032 0.2433 0.0709 Zn17-O35 O8-H37 0.319 0.145 0.0762 0.0470 0.0251 0.0025 − 0.1303 − 0.0413 − 0.0251 − 0.0025 0.1926 0.0605 The high charge densities of the O–H and M–O bonds, as well as a positive ∇2ρc, are suggested by the electron density features of the complexes. As a consequence, the electrostatic properties of O–H and M–O bonding may be stated to be reasonable. Indeed, a partly covalent connection is represented by a positive ∇2ρc and negative HC, while an electrostatic interaction is represented by a positive HC. Thus, the studied compounds showed positive ∇2ρc and negative HC, indicating polar covalent Be-O, Zn–O, and Mg-O bonds. Based on Table 2, the Favipiravir/(MgO)12 and Favipiravir/(ZnO)12 complexes showed high values, indicating strong Be-O, Zn–O, and Mg-O interactions. The Eads, FMO, and ESP findings accord with the AIM findings of these complexes.

Conclusions

The Favipiravir drugs’ adsorption onto fullerene-like (MO)12 NCs was investigated in this work. A study of the NC’s adsorption energies revealed that (MgO)12 and (ZnO)12 could significantly increase Favipiravir drugs’ adsorption on the NCs. Favipiravir/Be12O12 (30.22 kcal mol−1), Favipiravir/Zn12O12 (34.80 kcal mol−1), and Favipiravir/Mg12O12 (34.98 kcal mol−1) were rated in order of drug adsorption degrees. As a result, Favipiravir attachment to (MgO)12 and (ZnO)12 might be simple, increasing Favipiravir loading efficiency. In addition, the QTAIM assessment was used to look at the interactions between molecules. The Eads, FMO, NBO, and ESP reactivity patterns were shown to be in excellent agreement with the QTAIM data. The electrostatic properties of the system with the biggest positive charge on the M atom and the largest Eads were shown to be the best. This system was shown to be the best attraction site for nucleophilic agents. The findings show that (MgO)12 and (ZnO)12 have great carrier potential and may be used in medication delivery. However, more in vivo research is needed to confirm these findings.
  20 in total

1.  Semiempirical GGA-type density functional constructed with a long-range dispersion correction.

Authors:  Stefan Grimme
Journal:  J Comput Chem       Date:  2006-11-30       Impact factor: 3.376

2.  Van der Waals stacks of few-layer h-AlN with graphene: an ab initio study of structural, interaction and electronic properties.

Authors:  Renato B dos Santos; F de Brito Mota; R Rivelino; A Kakanakova-Georgieva; G K Gueorguiev
Journal:  Nanotechnology       Date:  2016-02-23       Impact factor: 3.874

3.  Structures and Stabilities of the Metal Doped Gold Nano-Clusters: M@Au10 (M = W, Mo, Ru, Co).

Authors:  Delwar Hossain; Charles U Pittman; Steven R Gwaltney
Journal:  J Inorg Organomet Polym Mater       Date:  2014-01-01       Impact factor: 3.543

4.  Exploring hydrogenation and fluorination in curved 2D carbon systems: a density functional theory study on corannulene.

Authors:  Renato B dos Santos; Roberto Rivelino; Fernando de B Mota; Gueorgui K Gueorguiev
Journal:  J Phys Chem A       Date:  2012-08-29       Impact factor: 2.781

5.  The H2 dissociation on the BN, AlN, BP and AlP nanotubes: a comparative study.

Authors:  Javad Beheshtian; Hamed Soleymanabadi; Mohammad Kamfiroozi; Ali Ahmadi
Journal:  J Mol Model       Date:  2011-10-07       Impact factor: 1.810

6.  [Inhibitors of RAS Might Be a Good Choice for the Therapy of COVID-19 Pneumonia].

Authors:  M L Sun; J M Yang; Y P Sun; G H Su
Journal:  Zhonghua Jie He He Hu Xi Za Zhi       Date:  2020-02-16

7.  Biocompatible Superparamagnetic Europium-Doped Iron Oxide Nanoparticle Clusters as Multifunctional Nanoprobes for Multimodal In Vivo Imaging.

Authors:  Tingting Zhang; Zhijie Wang; Huijing Xiang; Xue Xu; Jing Zou; Chichong Lu
Journal:  ACS Appl Mater Interfaces       Date:  2021-07-20       Impact factor: 9.229

8.  Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.

Authors:  Zhenming Jin; Xiaoyu Du; Yechun Xu; Yongqiang Deng; Meiqin Liu; Yao Zhao; Bing Zhang; Xiaofeng Li; Leike Zhang; Chao Peng; Yinkai Duan; Jing Yu; Lin Wang; Kailin Yang; Fengjiang Liu; Rendi Jiang; Xinglou Yang; Tian You; Xiaoce Liu; Xiuna Yang; Fang Bai; Hong Liu; Xiang Liu; Luke W Guddat; Wenqing Xu; Gengfu Xiao; Chengfeng Qin; Zhengli Shi; Hualiang Jiang; Zihe Rao; Haitao Yang
Journal:  Nature       Date:  2020-04-09       Impact factor: 49.962

9.  Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.

Authors:  Qingxian Cai; Minghui Yang; Dongjing Liu; Jun Chen; Dan Shu; Junxia Xia; Xuejiao Liao; Yuanbo Gu; Qiue Cai; Yang Yang; Chenguang Shen; Xiaohe Li; Ling Peng; Deliang Huang; Jing Zhang; Shurong Zhang; Fuxiang Wang; Jiaye Liu; Li Chen; Shuyan Chen; Zhaoqin Wang; Zheng Zhang; Ruiyuan Cao; Wu Zhong; Yingxia Liu; Lei Liu
Journal:  Engineering (Beijing)       Date:  2020-03-18       Impact factor: 7.553

10.  Fragment Molecular Orbital Based Interaction Analyses on COVID-19 Main Protease - Inhibitor N3 Complex (PDB ID: 6LU7).

Authors:  Ryo Hatada; Koji Okuwaki; Yuji Mochizuki; Yuma Handa; Kaori Fukuzawa; Yuto Komeiji; Yoshio Okiyama; Shigenori Tanaka
Journal:  J Chem Inf Model       Date:  2020-06-25       Impact factor: 4.956

View more
  3 in total

1.  Fullerene Derivatives for Drug Delivery against COVID-19: A Molecular Dynamics Investigation of Dendro[60]fullerene as Nanocarrier of Molnupiravir.

Authors:  Georgios I Giannopoulos
Journal:  Nanomaterials (Basel)       Date:  2022-08-07       Impact factor: 5.719

2.  Trivalent and pentavalent atoms doped boron nitride nanosheets as Favipiravir drug carriers for the treatment of COVID-19 using computational approaches.

Authors:  Afiya Akter Piya; Tanvir Ahmed; Md Abdul Khaleque; Kabir Ahmed; Siraj Ud Daula Shamim
Journal:  Comput Theor Chem       Date:  2022-09-30       Impact factor: 2.292

3.  Size-dependent adsorption performance of ZnO nanoclusters for drug delivery applications.

Authors:  Mustafa Kurban; İskender Muz
Journal:  Struct Chem       Date:  2022-09-30       Impact factor: 1.795

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.